Literature DB >> 21287206

Ultrasound-guided peripheral nerve blocks for a patient receiving four kinds of anticoagulant and antiplatelet drugs: a case report.

Hideki Taninishi, Kiyoshi Morita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21287206     DOI: 10.1007/s00540-011-1093-8

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  5 in total

1.  Ultrasound-guided infraclavicular block in an anticoagulated and anesthetized patient.

Authors:  Paul E Bigeleisen
Journal:  Anesth Analg       Date:  2007-05       Impact factor: 5.108

2.  Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.

Authors:  Adnan K Chhatriwalla; Deepak L Bhatt
Journal:  Circ Cardiovasc Interv       Date:  2008-12       Impact factor: 6.546

3.  Continuous peripheral nerve block in combat casualties receiving low-molecular weight heparin.

Authors:  C C Buckenmaier; C H Shields; A A Auton; S L Evans; S M Croll; L L Bleckner; D S Brown; A Stojadinovic
Journal:  Br J Anaesth       Date:  2006-10-09       Impact factor: 9.166

Review 4.  Ultrasound guidance compared with electrical neurostimulation for peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials.

Authors:  M S Abrahams; M F Aziz; R F Fu; J-L Horn
Journal:  Br J Anaesth       Date:  2009-01-26       Impact factor: 9.166

5.  Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition).

Authors:  Terese T Horlocker; Denise J Wedel; John C Rowlingson; F Kayser Enneking; Sandra L Kopp; Honorio T Benzon; David L Brown; John A Heit; Michael F Mulroy; Richard W Rosenquist; Michael Tryba; Chun-Su Yuan
Journal:  Reg Anesth Pain Med       Date:  2010 Jan-Feb       Impact factor: 6.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.